Published in Surgery on January 01, 1990
The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg (2006) 1.90
What is the best surgical treatment for anorectal melanoma? Int J Colorectal Dis (2003) 1.86
Primary anorectal melanoma: an update. J Cancer (2012) 1.55
Surgical treatment for anorectal malignant melanoma: report of five cases and review of 79 Japanese cases. Int J Colorectal Dis (2008) 1.50
Anorectal melanoma: surgical management guidelines according to tumour thickness. Br J Cancer (2003) 1.37
Anorectal malignant melanoma: treatment with surgery or radiation therapy, or both. Can J Surg (2003) 1.06
Anal melanoma. Clin Colon Rectal Surg (2006) 1.00
Anorectal melanoma. Clin Colon Rectal Surg (2011) 0.99
Anal versus rectal melanoma: does site of origin predict outcome? Dis Colon Rectum (2013) 0.97
Effect of misdiagnosis on the prognosis of anorectal malignant melanoma. J Cancer Res Clin Oncol (2010) 0.93
Treatment outcomes of anorectal melanoma. J Korean Soc Coloproctol (2011) 0.85
Synchronous anorectal melanoma. World J Gastroenterol (2006) 0.82
Locoregional lymphadenectomy in the surgical management of anorectal melanoma. Ann Surg Oncol (2013) 0.81
Primary anorectal melanoma: A case report with extended follow-up. Am J Case Rep (2012) 0.81
Malignant melanoma of the rectum. J Clin Imaging Sci (2014) 0.79
Primary anorectal malignant melanoma treated with neoadjuvant chemoradiotherapy and sphincter-sparing surgery: A case report. Oncol Lett (2014) 0.78
Amelanotic Anorectal Malignant Melanoma: Case Report with Immunohistochemical Study and Literature Review. Case Rep Oncol (2009) 0.78
Primary anorectal malignant melanoma: a rare but aggressive tumor: report of a case. World J Surg Oncol (2015) 0.78
Surgery of primary melanomas. Cancers (Basel) (2010) 0.77
Melanoma of the anus disguised as hemorrhoids: surgical management illustrated by a case report. Dig Dis Sci (2007) 0.77
A pilot study of extralevator abdominoperineal excision for primary melanoma of the anorectum. Tech Coloproctol (2014) 0.76
Anorectal melanoma metastatic to the breast: a case report and review of the literature. Onco Targets Ther (2016) 0.75
SYNCHRONOUS ANAL MELANOMA AND COLON ADENOCARCINOMA: CASE REPORT AND REVIEW OF DIAGNOSIS AND MANAGEMENT. Arq Bras Cir Dig (2017) 0.75
Surgical and radiation therapy management of recurrent anal melanoma. J Gastrointest Oncol (2014) 0.75
Anorectal melanoma. Successful palliation in a 59-year-old woman. West J Med (1996) 0.75
Multiple bilateral choroidal metastasis from anal melanoma. Int J Clin Oncol (2007) 0.75
Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases. Hum Pathol (1986) 3.65
Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg (1998) 3.11
Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev (1993) 2.82
The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens. J Immunol (1989) 2.32
Late recurrence of malignant melanoma. Analysis of 168 patients. Ann Surg (1990) 2.27
Improved computer program data for the resolution and fractionation of macromolecules by isokinetic sucrose density gradient sedimentation. Anal Biochem (1974) 2.06
Metastatic melanoma in the thorax: report of 130 patients. AJR Am J Roentgenol (1981) 1.95
Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol (1995) 1.94
Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg (1995) 1.90
Minimal carcinoma in prostate needle biopsy specimens: diagnostic features and radical prostatectomy follow-up. Mod Pathol (1998) 1.81
Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. Hum Pathol (1985) 1.81
Prognostic value of various morphometric measurements of tumour extent in prostate needle core tissue. Histopathology (2008) 1.80
MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele. J Immunol (1991) 1.60
Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract. Surgery (1984) 1.59
Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome. Arch Surg (1994) 1.56
Melanoma of the gallbladder: a review of cases seen at Duke University Medical Center. Cancer (1999) 1.54
The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining. Am J Clin Pathol (1998) 1.47
Malignant melanoma and pregnancy. Cancer (1985) 1.47
Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients. Ann Surg (1994) 1.41
Monoamine oxidase and catechol-O-methyltransferase activity in hamster and rat insulinomas. Diabetologia (1979) 1.41
Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanoma. J Natl Cancer Inst (1993) 1.40
Sinus histiocytosis with massive lymphadenopathy. Case report and review of a multisystemic disease with cutaneous infiltrates. J Am Acad Dermatol (1988) 1.39
Intercellular junctions and tumor behavior in lung cancer. Mod Pathol (1991) 1.38
Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res (1994) 1.38
Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci U S A (1984) 1.33
Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues. Mod Pathol (1997) 1.32
Comparative study of systemic interferon alfa-nl and isotretinoin in the treatment of resistant condylomata acuminata. J Am Acad Dermatol (1989) 1.32
Lethal "thin" malignant melanoma. Identifying patients at risk. Ann Surg (1988) 1.30
Skin graft rejection between subjects genotyped for HL-A. Transplant Proc (1969) 1.29
Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg (1992) 1.28
Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center. Surgery (1998) 1.28
Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg (1983) 1.26
Positron emission tomography scanning in malignant melanoma. Cancer (2000) 1.25
The ratio of prostate chips with cancer: a new measure of tumor extent and its relationship to grade and prognosis. Hum Pathol (1988) 1.23
Prostate cancer and chip specimens: complete versus partial sampling. Hum Pathol (1986) 1.23
Central nervous system metastases in malignant melanoma. Neurosurgery (1981) 1.21
Renal cell carcinoma with rhabdoid features. Am J Surg Pathol (2000) 1.20
Pulmonary morphology in a multihospital collaborative extracorporeal membrane oxygenation project. I. Light microscopy. Am J Pathol (1979) 1.19
Abnormalitieis of monocyte chemotaxis in patients with melanoma: effects of immunotherapy and tumor removal. J Natl Cancer Inst (1977) 1.18
Epidemiology of pulmonary lesions in nontextile and cotton textile workers: a retrospective autopsy analysis. Arch Environ Health (1980) 1.18
Selection of patients for heterotopic implantation of the areola and nipple. Surg Gynecol Obstet (1980) 1.17
Multiple primary melanoma: incidence and risk factors in 283 patients. Surgery (1993) 1.16
Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. Ann Surg (2001) 1.15
Anomalous MLR responsiveness among siblings. Transplant Proc (1971) 1.15
Hepatobiliary cystadenoma with mesenchymal stroma. Ann Surg (1990) 1.14
Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice. Cancer Res (1977) 1.14
Recurrent malignant melanoma: the identification of prognostic factors to predict survival. Ann Plast Surg (1992) 1.13
Melanoma-specific cytotoxic T cells generated from peripheral blood lymphocytes. Implications of a renewable source of precursors for adoptive cellular immunotherapy. Ann Surg (1989) 1.10
Changes in individual plasma amino acids following experimentally induced and fly fever virus infection. Metabolism (1972) 1.10
Histologic factors of prognostic significance in the glioblastoma multiforme. Cancer (1980) 1.09
Incidence of anatomical variants in renal vasculature in the presence of normal renal function. Ann Surg (1978) 1.09
The role of resection in the management of melanoma metastatic to the adrenal gland. Surgery (1991) 1.09
Role of surgical intervention in the management of intestinal metastases from malignant melanoma. Am J Surg (1991) 1.08
Metastatic malignant melanoma with an unknown primary. Surg Gynecol Obstet (1983) 1.06
Non-specific and specific immunotherapy in patients with melanoma. Surgery (1972) 1.06
Renal transplantation between HL-A identical donor-recipient pairs. Functional and morphological evaluation. J Clin Invest (1972) 1.05
Immunogenetics of consanguineous allografts in man. II. Correlation of renal allografting with HL-A genotyping. Ann Surg (1970) 1.04
Primary malignant melanoma of the esophagus. J Surg Oncol (1997) 1.04
Gastrointestinal carcinoids: characterization by site of origin and hormone production. Ann Surg (2000) 1.03
Malignant melanoma arising during pregnancy. A study of 100 patients. Ann Surg (1990) 1.03
Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men. Prostate Cancer Prostatic Dis (2011) 1.03
Analysis of prognosis and disease progression after local recurrence of melanoma. Cancer (2000) 1.02
Specific active immunotherapy for melanoma. Ann Surg (1979) 1.02
Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens. Hum Pathol (1990) 1.02
DTIC, CCNU, bleomycin and vincristine (BOLD) in metastatic melanoma. Cancer (1980) 1.02
Malignant melanoma of the mucous membranes: a review of 119 cases. Ann Surg Oncol (1998) 1.01
Immunogenetics of consanguineous allografts in man. I. Histocompatibility testing and skin allografts. Ann Surg (1970) 1.01
The annual risk of melanoma progression. Implications for the concept of cure. Cancer (1992) 1.00
Malignant melanoma in black American and white American populations. A comparative review. JAMA (1982) 0.99
Subungual melanoma. A review of 93 cases with identification of prognostic variables. Clin Orthop Relat Res (2000) 0.98
Autologous lymph node cell-derived tumor-specific cytotoxic T-cells for use in adoptive immunotherapy of human melanoma. Cancer (1988) 0.98
Acral melanoma: a review of 185 patients with identification of prognostic variables. J Surg Oncol (1990) 0.98
Postoperative function of "free" jejunal transplants for replacement of the cervical esophagus. Ann Surg (1980) 0.97
Current management of melanoma. Ann Surg (1977) 0.97
Rejection of canine cardiac allografts. Am J Pathol (1968) 0.97
HL-A antigenic loss in malignant transformation. J Natl Cancer Inst (1971) 0.97
Malignant melanoma. A multivariate analysis of prognostic factors. Pathol Annu (1989) 0.96
Prognosis for recurrent stage I malignant melanoma. Arch Surg (1987) 0.96
The immunogenicity of human HL-A haplotypesas measured by skin graft survival times and mixed leukocyte reactions. J Exp Med (1971) 0.95
Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive cases. J Natl Cancer Inst (1988) 0.95
Scatter factor-hepatocyte growth factor elevation in the serum of patients with prostate cancer. J Urol (2001) 0.94
Radiologic, endoscopic and surgical considerations of malignant melanoma metastatic to the small intestine. Curr Surg (1984) 0.94
Cloacogenic carcinoma. Ann Surg (1978) 0.93
Relationship between disease-free interval and survival in patients with recurrent melanoma. Arch Surg (1992) 0.93
Long-term clinical outcome of immediate reconstruction after mastectomy. Plast Reconstr Surg (1985) 0.93
Sex related survival differences in instances of melanoma. Surg Gynecol Obstet (1984) 0.92
Pectoralis pyomyositis: an unusual cause of chest wall pain in a patient with diabetes mellitus and rheumatoid arthritis. J Rheumatol (1986) 0.92
HL A typing, mixed leukocyte reactivity, and skin graft survival in a family with a recombinant at the HL-1 chromosomal region (major transplantation region). Transplantation (1973) 0.91
Surgical control of clinically localized prostate carcinoma is equivalent in African-American and white males. Cancer (1998) 0.91
Melanoma of the foot. J Bone Joint Surg Am (1994) 0.91
Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. J Thorac Cardiovasc Surg (1993) 0.91
Percutaneous transluminal renal artery angioplasty in a 3 1/2-year-old hypertensive girl. J Pediatr (1980) 0.90
Anorectal melanoma: clinical characteristics and the role of abdominoperineal resection. Ann Plast Surg (1992) 0.90